Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

From angiogenesis to lymphangiogenesis

Vascular endothelial growth factors are well-known angiogenic agents and targets for anti-cancer therapies. Now it appears that this signaling pathway is also involved in developmental and tumor-induced lymphangiogenesis (pages 186-191, 192-198, 199-205).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Dissecting tumor angiogenesis. Hypoxic tumor cells produce VEGF , which binds to and activates VEGFR-2 on vascular endothelial cells, leading to classical tumor angiogenesis.

Stephen Horwitz

References

  1. Thun M.J. & Wingo P.A. in Cancer Medicine 5th Edition (eds. Bast, R.C. Jr. et al.) 283–297 (B.C. Becker, Hamilton, Ontario, Canada, 2000).

    Google Scholar 

  2. Cotran, R.S., Kumar, V. & Collins T. Pathologic basis of disease. 6th Edition. (W.B. Saunders, Philadelphia, Pennsylvania, 1999).

    Google Scholar 

  3. Mäkinen, T. et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nature Med. 7, 199–205 (2001).

    Article  Google Scholar 

  4. Skobe, M. et al. Induction of tumor lymphangiogenesis by vascular endothelial growth factor-C promotes breast cancer metastasis. Nature Med. 7, 192–198 (2001).

    Article  CAS  Google Scholar 

  5. Stacker, S.A. et al. Vascular endothelial growth factor-D promotes the metastatic spread of tumors via the lymphatics. Nature Med. 7, 186–191 (2001).

    Article  CAS  Google Scholar 

  6. Mandriota, S.J. et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J. (in the press).

  7. Ferrara, N. & Hetzel, W.J. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Comm. 161, 851–858 (1989).

    Article  CAS  Google Scholar 

  8. Risau, W. Mechanisms of angiogenesis. Nature 386, 671–674, (1997).

    Article  CAS  Google Scholar 

  9. McMahon, G. VEGF receptor signaling in tumor angiogenesis. The Oncologist 5, s3–s10 (2000).

    Article  Google Scholar 

  10. Kaipanen, A. et al. Expression of the Fms-Like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566–3570 (1995).

    Article  Google Scholar 

  11. Joukov, V. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290–298 (1996).

    Article  CAS  Google Scholar 

  12. Achen, M.G. et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc. Natl. Acad. Sci. USA 95, 584–553 (1998).

    Article  Google Scholar 

  13. Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789–801 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plate, K. From angiogenesis to lymphangiogenesis. Nat Med 7, 151–152 (2001). https://doi.org/10.1038/84579

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/84579

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing